410 related articles for article (PubMed ID: 27444932)
1. Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular Disease.
Ngo D; Sinha S; Shen D; Kuhn EW; Keyes MJ; Shi X; Benson MD; O'Sullivan JF; Keshishian H; Farrell LA; Fifer MA; Vasan RS; Sabatine MS; Larson MG; Carr SA; Wang TJ; Gerszten RE
Circulation; 2016 Jul; 134(4):270-85. PubMed ID: 27444932
[TBL] [Abstract][Full Text] [Related]
2. Application of Large-Scale Aptamer-Based Proteomic Profiling to Planned Myocardial Infarctions.
Jacob J; Ngo D; Finkel N; Pitts R; Gleim S; Benson MD; Keyes MJ; Farrell LA; Morgan T; Jennings LL; Gerszten RE
Circulation; 2018 Mar; 137(12):1270-1277. PubMed ID: 29222138
[TBL] [Abstract][Full Text] [Related]
3. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
Smith JG; Gerszten RE
Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
[TBL] [Abstract][Full Text] [Related]
4. Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury.
Lewis GD; Wei R; Liu E; Yang E; Shi X; Martinovic M; Farrell L; Asnani A; Cyrille M; Ramanathan A; Shaham O; Berriz G; Lowry PA; Palacios IF; Taşan M; Roth FP; Min J; Baumgartner C; Keshishian H; Addona T; Mootha VK; Rosenzweig A; Carr SA; Fifer MA; Sabatine MS; Gerszten RE
J Clin Invest; 2008 Oct; 118(10):3503-12. PubMed ID: 18769631
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients With Stable Coronary Heart Disease.
Ganz P; Heidecker B; Hveem K; Jonasson C; Kato S; Segal MR; Sterling DG; Williams SA
JAMA; 2016 Jun; 315(23):2532-41. PubMed ID: 27327800
[TBL] [Abstract][Full Text] [Related]
6. Aptamer-Based Proteomic Platform Identifies Novel Protein Predictors of Incident Heart Failure and Echocardiographic Traits.
Nayor M; Short MI; Rasheed H; Lin H; Jonasson C; Yang Q; Hveem K; Felix JF; Morrison AC; Wild PS; Morley MP; Cappola TP; Benson MD; ; ; Ngo D; Sinha S; Keyes MJ; Shen D; Wang TJ; Larson MG; Brumpton BM; Gerszten RE; Omland T; Vasan RS
Circ Heart Fail; 2020 May; 13(5):e006749. PubMed ID: 32408813
[TBL] [Abstract][Full Text] [Related]
7. Proteomic Discovery and Validation of the Confounding Effect of Heparin Administration on the Analysis of Candidate Cardiovascular Biomarkers.
Beck HC; Jensen LO; Gils C; Ilondo AMM; Frydland M; Hassager C; Møller-Helgestad OK; Møller JE; Rasmussen LM
Clin Chem; 2018 Oct; 64(10):1474-1484. PubMed ID: 30115630
[TBL] [Abstract][Full Text] [Related]
8. A new data mining approach for profiling and categorizing kinetic patterns of metabolic biomarkers after myocardial injury.
Baumgartner C; Lewis GD; Netzer M; Pfeifer B; Gerszten RE
Bioinformatics; 2010 Jul; 26(14):1745-51. PubMed ID: 20483816
[TBL] [Abstract][Full Text] [Related]
9. Multiplexed, Quantitative Workflow for Sensitive Biomarker Discovery in Plasma Yields Novel Candidates for Early Myocardial Injury.
Keshishian H; Burgess MW; Gillette MA; Mertins P; Clauser KR; Mani DR; Kuhn EW; Farrell LA; Gerszten RE; Carr SA
Mol Cell Proteomics; 2015 Sep; 14(9):2375-93. PubMed ID: 25724909
[TBL] [Abstract][Full Text] [Related]
10. A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease.
Addona TA; Shi X; Keshishian H; Mani DR; Burgess M; Gillette MA; Clauser KR; Shen D; Lewis GD; Farrell LA; Fifer MA; Sabatine MS; Gerszten RE; Carr SA
Nat Biotechnol; 2011 Jun; 29(7):635-43. PubMed ID: 21685905
[TBL] [Abstract][Full Text] [Related]
11. Aptamer-based proteomics of serum and plasma in acquired aplastic anemia.
Giudice V; Biancotto A; Wu Z; Cheung F; Candia J; Fantoni G; Kajigaya S; Rios O; Townsley D; Feng X; Young NS
Exp Hematol; 2018 Dec; 68():38-50. PubMed ID: 30312735
[TBL] [Abstract][Full Text] [Related]
12. Integration of proteomic-based tools for improved biomarkers of myocardial injury.
Gerszten RE; Carr SA; Sabatine M
Clin Chem; 2010 Feb; 56(2):194-201. PubMed ID: 20022985
[TBL] [Abstract][Full Text] [Related]
13. Genetic Architecture of the Cardiovascular Risk Proteome.
Benson MD; Yang Q; Ngo D; Zhu Y; Shen D; Farrell LA; Sinha S; Keyes MJ; Vasan RS; Larson MG; Smith JG; Wang TJ; Gerszten RE
Circulation; 2018 Mar; 137(11):1158-1172. PubMed ID: 29258991
[TBL] [Abstract][Full Text] [Related]
14. Myocardial Injury Is Distinguished from Stable Angina by a Set of Candidate Plasma Biomarkers Identified Using iTRAQ/MRM-Based Approach.
Cheow ESH; Cheng WC; Yap T; Dutta B; Lee CN; Kleijn DPV; Sorokin V; Sze SK
J Proteome Res; 2018 Jan; 17(1):499-515. PubMed ID: 29068691
[TBL] [Abstract][Full Text] [Related]
15. Comparison of proteomic methods in evaluating biomarker-AKI associations in cardiac surgery patients.
Liu RX; Thiessen-Philbrook HR; Vasan RS; Coresh J; Ganz P; Bonventre JV; Kimmel PL; Parikh CR
Transl Res; 2021 Dec; 238():49-62. PubMed ID: 34343625
[TBL] [Abstract][Full Text] [Related]
16. Novel Insights Into the Effects of Interleukin 6 Antagonism in Non-ST-Segment-Elevation Myocardial Infarction Employing the SOMAscan Proteomics Platform.
George MJ; Kleveland O; Garcia-Hernandez J; Palmen J; Lovering R; Wiseth R; Aukrust P; Engmann J; Damås JK; Hingorani AD; Gullestad L; Casas JP; Ueland T
J Am Heart Assoc; 2020 Jun; 9(12):e015628. PubMed ID: 32515246
[TBL] [Abstract][Full Text] [Related]
17. Sorbin and SH3 domain-containing protein 2 is released from infarcted heart in the very early phase: proteomic analysis of cardiac tissues from patients.
Kakimoto Y; Ito S; Abiru H; Kotani H; Ozeki M; Tamaki K; Tsuruyama T
J Am Heart Assoc; 2013 Dec; 2(6):e000565. PubMed ID: 24342996
[TBL] [Abstract][Full Text] [Related]
18. Angiographic and clinical characteristics of type 1 versus type 2 perioperative myocardial infarction.
Hanson I; Kahn J; Dixon S; Goldstein J
Catheter Cardiovasc Interv; 2013 Oct; 82(4):622-8. PubMed ID: 22926992
[TBL] [Abstract][Full Text] [Related]
19. An aptamer-based trypsin reactor for on-line protein digestion with electrospray ionization tandem mass spectrometry.
Xiao P; Lv X; Wang S; Iqbal J; Qing H; Li Q; Deng Y
Anal Biochem; 2013 Oct; 441(2):123-32. PubMed ID: 23831476
[TBL] [Abstract][Full Text] [Related]
20. Protein biomarkers of new-onset cardiovascular disease: prospective study from the systems approach to biomarker research in cardiovascular disease initiative.
Yin X; Subramanian S; Hwang SJ; O'Donnell CJ; Fox CS; Courchesne P; Muntendam P; Gordon N; Adourian A; Juhasz P; Larson MG; Levy D
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):939-45. PubMed ID: 24526693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
